fluoropyrimidine
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for fluoropyrimidine, covering 2021-10-28 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer [Phase 3]